Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05924165 · ClinicalTrials.gov registry record · Phase 4
Narcotic-Free Percutaneous Nephrolithotomy
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT05924165 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 90 participants.
The verdict
NCT05924165, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is a randomized control trial comparing oral ketorolac and opioid medication for the use of post-operative analgesia.
Interventions
- DRUG 5mg Oxycodone, Q6 PRN
- DRUG 10mg Ketorolac, Q6 PRN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-05-19 |
| Est. Completion | 2025-01-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05924165
The ClinicalTrials.gov registry entry for NCT05924165 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5mg Oxycodone, Q6 PRN is the first listed.
NCT05924165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05924165 about?
NCT05924165 is a clinical study titled "Narcotic-Free Percutaneous Nephrolithotomy". This is a randomized control trial comparing oral ketorolac and opioid medication for the use of post-operative analgesia.
What is the current status of trial NCT05924165?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2023-05-19. Estimated completion is 2025-01-07.
What interventions are being tested in trial NCT05924165?
The interventions under investigation include: 5mg Oxycodone, Q6 PRN (DRUG), 10mg Ketorolac, Q6 PRN (DRUG).
Who is sponsoring clinical trial NCT05924165?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.